Stephen M. Ansell
Toyota Motor Corporation (Switzerland)(CH)Mayo Clinic(US)WinnMed(US)Mayo Clinic in Arizona(US)Mayo Clinic in Florida(US)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction
Most-Cited Works
- → PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma(2014)3,522 cited
- → Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma(2012)1,502 cited
- → The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee(2022)1,387 cited
- → Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study(2016)1,004 cited
- → Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing(2012)978 cited
- → Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial(2016)915 cited